Jacob Hooker
From Wikipedia, the free encyclopedia
Jacob Hooker | |
|---|---|
 | |
| Alma mater | North Carolina State University (BS) University of California, Berkeley (PhD) |
| Known for | Developed PET radiotracers for measuring biochemistry in the human brain |
| Awards | Presidential Early Career Award for Scientists and Engineers (2010) |
| Scientific career | |
| Fields | Chemistry, neuroscience and drug development[1] |
| Institutions | Harvard Medical School Massachusetts General Hospital |
| Doctoral advisor | Matthew Francis (Doctoral Advisor)[2] Joanna Fowler (Postdoctoral Advisor) [3] |
Jacob M. Hooker is an American chemist and expert in molecular imaging, specifically in the development and application of combined MRI and PET. He is the Lurie FamilyProfessor of Radiology specializing in Autism Research at Harvard Medical School.[4] He also serves as a Phyllis and Jerome Lyle Rappaport MGH Research Scholar, director of radiochemistry at the Martinos Center for Biomedical Imaging and scientific director at the Lurie Center for Autism at Massachusetts General Hospital.[5]
He grew up outside of Asheville, North Carolina and attended Enka High School. Hooker received a B.S. in Textile Chemistry and Chemistry from North Carolina State University in 2002 and later earned a Ph.D. in Chemistry from the University of California, Berkeley[6] Hooker then completed postdoctoral training under the mentorship of Joanna Fowler at the Brookhaven National Laboratory,[7] as a Goldhaber Distinguished Fellow, developing new neuroscience-oriented imaging methods and protocols.[8]
Career
Hooker relocated to Boston,Massachusetts in 2009 at the initiation of his independent research career at the Martinos Center.[9] He co-designed and built a cyclotron and radiopharmacy facility housing a Siemens Eclipse HP Cyclotron, completed early 2011.[10] At Massachusetts General Hospital, Hooker co-founded and co-directs an imaging facility that combines functional MRI and positron emission tomography (PET) for the neurochemical study of the Human Brain.[11] He holds associate appointments at the Broad Institute and the Massachusetts Institute of Technology (MIT).[12] From 2017 to 2021, Hooker co-founded Eikonizo Therapeutics and later Sensorium Therapeutics.[13] He is also Editor-in-Chief of ACS Chemical Neuroscience.[14]
Hooker has been a Scientific Advisor for Delix Therapeutics, Psy Therapeutics, Inc., and Fuzionaire Diagnostics.[15] He is also chief science advisor to Rocket Science Health.[16]
